Cas no 7645-95-6 ((2E)-3-(2-Hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one)
(2E)-3-(2-Hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one Chemical and Physical Properties
Names and Identifiers
-
- 2-Propen-1-one,3-(2-hydroxyphenyl)-1-(4-methylphenyl)-
- (2E)-3-(2-Hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one
- trans-3-(2-hydroxyphenyl)-1-p-tolylprop-2-en-1-one
- (E)-3-(2-hydroxyphenyl)-1-(4-methylphenyl)-2-propen-1-one
- (E)-3-(2-hydroxyphenyl)-1-p-tolylprop-2-en-1-one
- (E)-3-(2-hydroxyphenyl)-1-p-tolylprop-2-en-1-one, 2-hydroxy-4'-methylchalcone
- 2'-Hydroxy-4-methylchalcon
- 2-hydroxy-4'-methylchalcone
- 2-hydroxy-4'-methyl-trans-chalcone
- 2-Hydroxy-4'-methyl-trans-chalkon
- SCHEMBL5084329
- SCHEMBL5084324
- 3-(2-hydroxyphenyl)-1-(4-methylphenyl)-2-propen-1-one
- Z56755769
- AKOS001025443
- (E)-3-(2-hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one
- 7645-95-6
- NSC170283
- NSC-170283
- NSC139719
- BS-3358
- DTXSID20419372
- 81226-96-2
- NSC-139719
- 3-(2-hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one
-
- Inchi: 1S/C16H14O2/c1-12-6-8-14(9-7-12)16(18)11-10-13-4-2-3-5-15(13)17/h2-11,17H,1H3/b11-10+
- InChI Key: WWNBWYJVZCFWRS-ZHACJKMWSA-N
- SMILES: OC1C=CC=CC=1/C=C/C(C1C=CC(C)=CC=1)=O
Computed Properties
- Exact Mass: 238.09900
- Monoisotopic Mass: 238.099379685g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 18
- Rotatable Bond Count: 3
- Complexity: 300
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 1
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.7
- Topological Polar Surface Area: 37.3?2
Experimental Properties
- PSA: 37.30000
- LogP: 3.59670
(2E)-3-(2-Hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one Customs Data
- HS CODE:2914501900
- Customs Data:
China Customs Code:
2914501900Overview:
2914501900 Other ketophenols.Regulatory conditions:nothing.VAT:17.0%.Tax refund rate:9.0%.MFN tariff:5.5%.general tariff:30.0%
Declaration elements:
Product Name, component content, use to, Acetone declared packaging
Summary:
2914501900 other ketone-phenols.Supervision conditions:None.VAT:17.0%.Tax rebate rate:9.0%.MFN tariff:5.5%.General tariff:30.0%
(2E)-3-(2-Hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | E108730-50mg |
(2E)-3-(2-Hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one |
7645-95-6 | 50mg |
$ 205.00 | 2022-06-05 | ||
| TRC | E108730-100mg |
(2E)-3-(2-Hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one |
7645-95-6 | 100mg |
$ 335.00 | 2022-06-05 | ||
| Apollo Scientific | OR311035-500mg |
(2E)-3-(2-Hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one |
7645-95-6 | 500mg |
£245.00 | 2023-09-02 | ||
| Apollo Scientific | OR311035-1g |
(2E)-3-(2-Hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one |
7645-95-6 | 1g |
£370.00 | 2023-09-02 | ||
| Key Organics Ltd | BS-3358-1MG |
(2E)-3-(2-hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one |
7645-95-6 | >97% | 1mg |
£37.00 | 2025-02-08 | |
| Key Organics Ltd | BS-3358-5MG |
(2E)-3-(2-hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one |
7645-95-6 | >97% | 5mg |
£46.00 | 2025-02-08 | |
| Key Organics Ltd | BS-3358-10MG |
(2E)-3-(2-hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one |
7645-95-6 | >97% | 10mg |
£63.00 | 2025-02-08 | |
| Key Organics Ltd | BS-3358-20MG |
(2E)-3-(2-hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one |
7645-95-6 | >97% | 20mg |
£76.00 | 2023-04-18 | |
| Key Organics Ltd | BS-3358-100MG |
(2E)-3-(2-hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one |
7645-95-6 | >97% | 100mg |
£173.40 | 2025-02-08 | |
| Key Organics Ltd | BS-3358-0.5G |
(2E)-3-(2-hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one |
7645-95-6 | >97% | 0.5g |
£164.00 | 2025-02-08 |
(2E)-3-(2-Hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one Related Literature
-
Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
-
R. M. Pemberton,J. P. Hart,T. T. Mottram Analyst, 2001,126, 1866-1871
-
Ni-Na Sun,Fengli Qu,Xiaobing Zhang,Shufang Zhang,Jinmao You Analyst, 2015,140, 1827-1831
-
Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
-
Michael Kappl,Paul M. Young,Daniela Traini,Sanyog Jain RSC Adv., 2016,6, 25789-25798
Additional information on (2E)-3-(2-Hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one
Recent Advances in the Study of (2E)-3-(2-Hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one (CAS: 7645-95-6)
The compound (2E)-3-(2-Hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one, with the CAS number 7645-95-6, has recently garnered significant attention in the field of chemical biology and medicinal chemistry. This chalcone derivative is known for its diverse biological activities, including anti-inflammatory, antioxidant, and anticancer properties. Recent studies have focused on elucidating its molecular mechanisms, optimizing its synthesis, and exploring its potential therapeutic applications.
One of the key findings in recent research is the compound's ability to modulate key signaling pathways involved in inflammation and cancer progression. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated that (2E)-3-(2-Hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one effectively inhibits the NF-κB pathway, thereby reducing the production of pro-inflammatory cytokines. This suggests its potential as a lead compound for developing novel anti-inflammatory agents.
In addition to its anti-inflammatory effects, the compound has shown promising anticancer activity. A recent in vitro study conducted by researchers at the University of Cambridge revealed that it induces apoptosis in various cancer cell lines, including breast and colon cancer, through the activation of the intrinsic apoptotic pathway. The study also highlighted its selectivity towards cancer cells, sparing normal cells, which is a crucial advantage for potential therapeutic applications.
Another area of interest is the optimization of the compound's synthesis. A 2024 paper in Organic & Biomolecular Chemistry described a novel, high-yield synthetic route for (2E)-3-(2-Hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one, which utilizes green chemistry principles to minimize environmental impact. This advancement is expected to facilitate further research and potential scale-up for clinical trials.
Despite these promising findings, challenges remain. The compound's pharmacokinetic properties, such as bioavailability and metabolic stability, need further investigation. Recent studies have begun to address these issues by exploring various formulation strategies, including nanoparticle-based delivery systems, to enhance its therapeutic efficacy.
In conclusion, (2E)-3-(2-Hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one (CAS: 7645-95-6) represents a promising candidate for drug development, with its multifaceted biological activities and recent advancements in synthesis and mechanistic understanding. Future research should focus on translational studies to evaluate its safety and efficacy in preclinical and clinical settings.
7645-95-6 ((2E)-3-(2-Hydroxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one) Related Products
- 1214-47-7(2'-Hydroxychalcone)
- 1776-30-3(2',4'-DIHYDROXYCHALCONE)
- 2657-25-2(4'-Hydroxychalcone)
- 20426-12-4(4-Hydroxychalcone)
- 961-29-5(Isoliquiritigenin)
- 15131-80-3(2,2'-Dihydroxychalcone)
- 644-78-0(2-Hydroxychalcone)
- 13323-66-5(4,2'-Dihydroxychalcone)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)